Correx corrals $2.8M in second funding round
Waltham-based surgical device company Correx Inc. has landed $2.8 million of a planned $4 million financing round – the second the company has taken since it was founded in 2004, according to federal documents.
Correx first raised $4.5 million in 2008, according to the company’s filings with the U.S. Securities and Exchange Commission. None of the 10 investors in the latest round of Correx are identified in the filing, which only notes CEO Alan Crunkleton and director Joel Braunstein of Harvard Medical School as involved with the company. Braunstein is co-founder and managing partner of LifeTech Development Partners, which invested in Correx’s Series A round, according to the Correx website.